Clinical Trials Logo

Cholecystitis clinical trials

View clinical trials related to Cholecystitis.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT04167072 Withdrawn - Clinical trials for Cholecystitis, Acute

Observation vs Early Removal of LAMS in EUS Guided Cholecystoenterostomy

Start date: November 1, 2019
Phase: N/A
Study type: Interventional

The study will compare the outcomes of patients with gallstone related cholecystitis who are poor surgical candidates undergoing EUS guided cholecystoenterostomy via a lumen apposing metal stent (LAMS).

NCT ID: NCT04145869 Withdrawn - Acute Cholecystitis Clinical Trials

Fluorescent Cholangiography During Acute Cholecystitis

Start date: April 1, 2020
Phase: N/A
Study type: Interventional

This study compares the visualizationrate of fluorescent and X-ray cholangiography during laparoscopic cholecystectomy for acute cholecystitis

NCT ID: NCT03087747 Withdrawn - Clinical trials for Cholecystitis, Acute

Percutaneous Transhepatic Cholangiography (PTHC) in Acute Cholecystitis and Clinical Outcomes

Start date: January 1, 2015
Phase:
Study type: Observational [Patient Registry]

In a setting of acute cholecystitis (AC) one of the treatment option is percutaneous transhepatic cholangiography (PTHC) drainage. The goal of current study is to evaluate some radiology aspects and correlate with clinical patient outcomes in patients with acute cholecystitis severity grade III (presented as acute cholecystitis with organ dysfunction).

NCT ID: NCT02225418 Withdrawn - Pain Clinical Trials

Transmuscular Quadratus Lumborum Block for Laparoscopic Cholecystectomy

TQL
Start date: November 2014
Phase: N/A
Study type: Interventional

The TQL block may prove a valuable method for treating postoperative pain following scopic removal of the gall bladder. The trial will compare active TQL block versus placebo TQL block after said operation. The hypothesis is that active TQL block significantly will reduce postoperative pain following scopic removal of the gall bladder compared with placebo TQL block.

NCT ID: NCT02056678 Withdrawn - Clinical trials for Obstructive Sleep Apnea

Outcome of IV Acetaminophen Use in Laparoscopic Cholecystectomies in Patients at Risk of OSA

Start date: February 2014
Phase: Phase 4
Study type: Interventional

The objective of this study is to determine if IV acetaminophen administered intraoperatively can decrease the dose of narcotics required for adequate pain control and shorten recovery time in the PACU specifically in obese patients at risk for obstructive sleep apnea.

NCT ID: NCT00815438 Withdrawn - Cholecystitis Clinical Trials

Transvaginal Cholecystectomy Using Endoscopic Assistance

Start date: January 2009
Phase: Phase 1
Study type: Interventional

Surgical removal of the gallbladder is needed in 1 million people per year in the USA. The procedure is done by placing four tubes (cannula) from 5 to 10 mm through the abdominal wall. Air is placed in the abdominal cavity and a lighted scope is placed through one cannula. The space in the abdominal cavity can then be seen on a video screen. Thin retractors and dissecting instruments are placed through the other cannula and the gallbladder is removed using the video screen for vision. The gallbladder duct and the artery are usually occluded with clips or stitches. In this study we propose to do the procedure though a single 5 mm incision placed at the umbilicus and a second access through the vagina using a flexible endoscope. The gallbladder will be retracted using strings (sutures) attached to the gallbladder. The dissection will be done using laparoscopic instruments (scissors, knives, dissectors) placed through the laparoscopic port. A flexible grasper may be used in the endoscope to help with retraction. An endoscopic snare or grasper will be used to grasp the gallbladder and remove it from the abdomen through the vagina. This study evaluates the ability to do laparoscopic cholecystectomy with one skin incision and one vaginal incision. This will provide the basis for future studies evaluating decreased pain and costs with transvaginal assisted cholecystectomy.

NCT ID: NCT00634140 Withdrawn - Clinical trials for Chronic Acalculous Cholecystitis

The Influence of Ezetimibe on Gallbladder Function

Start date: August 2009
Phase: N/A
Study type: Interventional

Ezetimibe is a drug which inhibits the absorption of both dietary and biliary cholesterol in the small intestine. Ezetimibe has been approved for use in humans to lower serum cholesterol. The primary aim of this study is to determine if ezetimibe normalizes resting and residual volume in patients with chronic acalculous cholecystitis.

NCT ID: NCT00463762 Withdrawn - Appendicitis Clinical Trials

Cefoperazone/Sulbactam In The Treatment Of Serious Intra-Abdominal And Hepatobiliary Infections.

Start date: May 2007
Phase: Phase 4
Study type: Observational

The primary objective is to collect data on treatment outcomes (clinical and microbiological cure), safety and tolerability of treatment with cefoperazone/sulbactam in patients with serious intra-abdominal and hepatobiliary infections in Slovakia.